Our ambition in a changing landscape of psoriasis treatments

Finansiering

Van de Kerkhof received fees for consultancy service and lecturerships from Celgene, Almirall, Abbvie, Amgen, Eli Lilly, Novartis, Jansen Pharmaceutica, Leo Pharma, Bristol Mayer Squib, and Dermavant. He is chief medical officer of the International Psoriasis Council and member of the advisory board of the international Federation of Psoriasis Associations. He is chair of the Dutch burn Wound Association. Feldman received research, speaking, and/or consulting support from Galderma, GSK/Stiefel, Almirall, Alvotech, Leo Pharma, BMS, Boehringer Ingelheim, Mylan, Celgene, Pfizer, Ortho Dermatology, Abbvie, Samsung, Janssen, Lilly, Menlo, Merck, Novartis, Regeneron, Sanofi, Novan, Qurient, National Biological Corporation, Caremark, Advance Medical, Sun Pharma, Suncare Research, Informa, UpToDate, and National Psoriasis Foundation. He is founder and majority owner of www.DrScore.com and founder and part owner of Causa Research, a company dedicated to enhancing patients’ adherence to treatment.